ApoGen Biotechnologies
Seattle, US · Founded 2014 · Delaware corporation
Founders & leadership
TL
Thong LeNamed on SEC filing
KG
Keno GutierrezNamed on SEC filing
JS
John SantiniNamed on SEC filing
MJ
M. Johnston ErwinNamed on SEC filing
IA
Ian A.W. HowesNamed on SEC filing
JM
Joel MarcusNamed on SEC filing
JS
James SullivanNamed on SEC filing
Board
SG
Steve GillisBoard director
AX
Asish XavierBoard director
Reported raises · per SEC filings
Form D private placements$7.6M disclosed across 1 round · 2016
▶$7.6MraisedAug 2018 · 24 investors · BiotechnologyRule 506(b)
▶$7.6MraisedAug 2018 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thong LeExecutive Officer, Director
- Keno GutierrezDirector
- Steve GillisDirector
- John SantiniDirector
- M. Johnston ErwinDirector
- Asish XavierDirector
- Ian A.W. HowesExecutive Officer
- Joel MarcusDirector
- James SullivanDirector
- Offering amount
- $7.6M
- Amount sold
- $7.6M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ApoGen Biotechnologies raised?
- ApoGen Biotechnologies has disclosed $7.6M raised across 1 round.
- Where is ApoGen Biotechnologies headquartered?
- ApoGen Biotechnologies is headquartered in Seattle, US.